EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Fibrates and risk of congenital malformations: a nationwide cohort study in South Korea

Hee Yeon Kay, Ha Young Jang, In-Wha Kim, Jung Mi Oh

Archives of Gynecology and Obstetrics · 2024

DOI: 10.1007/s00404-023-07357-2 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Archives of Gynecology and Obstetrics, 2024. Verfasst von Hee Yeon Kay und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Abnormalities, Drug-Induced, Dyslipidemias, Fibric Acids. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seoul National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To examine the association between maternal prescriptions for fibrates and congenital malformations in live births.

Methods

Nationwide retrospective cohort study was conducted using the data sourced from the Korean National Health Insurance database. A cohort of 756,877 completed pregnancies linked to live-born infants in 215,600 women with dyslipidemia between 2012 and 2021. The study compared data on congenital anomalies between pregnancies who were exposed to fibrates and those who were not exposed to fibrates in the first trimester. Odds ratios (OR) were calculated by a multivariable analyses using logistic regression models to adjust for potential confounders.

Results

260 pregnancies (0.12%) were exposed to fibrates during the first trimester. The prevalence of malformations in exposed offspirng was 10.77%, not significantly different compared with 9.68% in offspring of women who were not prescribed fibrates during pregnancy in patients with dyslipidemia (OR 1.13; 95% CI 0.75–1.70).

Conclusion

This study implies that the use of fibrates during pregnancy may be safe, as it did not show any association with congenital anomalies. However, caution is warranted due to an elevated risk associated with prolonged exposure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abnormalities, Drug-InducedDyslipidemiasFibric AcidsHumansFemaleRepublic of KoreaPregnancyAdultRetrospective StudiesPregnancy ComplicationsPregnancy Trimester, FirstInfant, NewbornPrevalenceCohort StudiesHypolipidemic AgentsLogistic ModelsOdds Ratio

Stichwörter der Autor:innen

Drug-induced congenital abnormalitiesHypertriglyceridemiaLipid-lowering agentsPregnancy complicationsRetrospective cohort study

Substanzen

Fibric AcidsHypolipidemic Agents

Autor:innen und Institutionen

  • College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
  • College of Pharmacy, Gachon University, Incheon, 21936, Republic of Korea.
  • College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea. jmoh@snu.ac.kr.

Förderung

  • Seoul National University

Zitieren

APA

Kay, H. Y., Jang, H. Y., Kim, I. W., & Oh, J. M. (2024). Fibrates and risk of congenital malformations: a nationwide cohort study in South Korea. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-023-07357-2

Vancouver

Kay HY, Jang HY, Kim IW, Oh JM. Fibrates and risk of congenital malformations: a nationwide cohort study in South Korea. Archives of Gynecology and Obstetrics. 2024. doi:10.1007/s00404-023-07357-2

BibTeX
@article{Kay2024,
  author = {Kay, Hee Yeon and Jang, Ha Young and Kim, In-Wha and Oh, Jung Mi},
  title = {Fibrates and risk of congenital malformations: a nationwide cohort study in South Korea},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2024},
  doi = {10.1007/s00404-023-07357-2}
}
Kostenlos starten →